{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T18:59:10Z","timestamp":1787597950386,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,2,20]],"date-time":"2016-02-20T00:00:00Z","timestamp":1455926400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["3\/1\/3\/Ph.D(3)\/HRD-2014(9th Batch)"],"award-info":[{"award-number":["3\/1\/3\/Ph.D(3)\/HRD-2014(9th Batch)"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s10495-016-1229-2","type":"journal-article","created":{"date-parts":[[2016,2,20]],"date-time":"2016-02-20T09:55:16Z","timestamp":1455962116000},"page":"609-620","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["PAR-1 mediated apoptosis of breast cancer cells by V. cholerae hemagglutinin protease"],"prefix":"10.1007","volume":"21","author":[{"given":"Tanusree","family":"Ray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,20]]},"reference":[{"issue":"1","key":"1229_CR1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/138161210789941847","volume":"16","author":"A Urruticoechea","year":"2010","unstructured":"Urruticoechea A, Alemany R, Balart J, Villanueva A, Vi\u00f1als F, Capell\u00e1 G (2010) Recent advances in cancer therapy: an overview. Curr Pharm Des 16(1):3\u201310","journal-title":"Curr Pharm Des"},{"issue":"4","key":"1229_CR2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"S Elmore","year":"2007","unstructured":"Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35(4):495\u2013516","journal-title":"Toxicol Pathol"},{"issue":"12","key":"1229_CR3","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1172\/JCI9053","volume":"104","author":"WR Sellers","year":"1999","unstructured":"Sellers WR, Fisher DE (1999) Apoptosis and cancer drug targeting. J Clin Invest 104(12):1655\u20131661. doi: 10.1172\/JCI9053","journal-title":"J Clin Invest"},{"key":"1229_CR4","author":"T Ray","year":"2015","unstructured":"Ray T, Chakrabarti MK, Pal A (2015) Hemagglutinin protease secreted by V. cholerae induced apoptosis in breast cancer cells by ROS mediated intrinsic pathway and regresses tumor growth in mice model. Apoptosis. doi: 10.1007\/s10495-015-1194-11-12","journal-title":"Apoptosis"},{"key":"1229_CR5","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrd2092","volume":"5","author":"B Turk","year":"2006","unstructured":"Turk B (2006) Targeting proteases: successes, failures and future prospects. Nat Rev Drug Discov 5:785\u2013799","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"1229_CR6","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0002-9440(10)63200-2","volume":"164","author":"YA DeClerck","year":"2004","unstructured":"DeClerck YA, Mercurio AM, Stack MS, Chapman HA, Zutter MM, Muschel RJ et al (2004) Proteases, extracellular matrix, and cancer. Am J Pathol 164(4):1131\u20131139. doi: 10.1016\/S0002-9440(10)63200-2","journal-title":"Am J Pathol"},{"key":"1229_CR7","first-page":"563","volume":"47","author":"H Maeda","year":"1987","unstructured":"Maeda H, Matsumura Y, Molla A (1987) Antitumor activity of some bacterial proteases: eradication of solid tumors in mice by intratumor injection. Can Res 47:563\u2013566","journal-title":"Can Res"},{"key":"1229_CR8","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3892\/ol.2011.291","volume":"2","author":"N Han","year":"2011","unstructured":"Han N, Jin K, He K, Cao J, Teng L (2011) Protease-activated receptors in cancer: a systematic review. Oncol Lett 2:599\u2013608. doi: 10.3892\/ol.2011.291","journal-title":"Oncol Lett"},{"issue":"2","key":"1229_CR9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1476-5381.2010.00705.x","volume":"160","author":"UJ Soh","year":"2010","unstructured":"Soh UJ, Dores MR, Chen B, Trejo J (2010) Signal transduction by protease-activated receptors. Br J Pharmacol 160(2):191\u2013203. doi: 10.1111\/j.1476-5381.2010.00705.x","journal-title":"Br J Pharmacol"},{"key":"1229_CR10","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1023\/B:APPT.0000045784.49886.96","volume":"6","author":"AN Flynn","year":"2004","unstructured":"Flynn AN, Buret AG (2004) Proteinase-activated receptor 1 (PAR-1) and cell apoptosis. Apoptosis 6:729\u2013737","journal-title":"Apoptosis"},{"issue":"7","key":"1229_CR11","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/emboj.2012.42","volume":"31","author":"B Turk","year":"2012","unstructured":"Turk B, Turk D, Turk V (2012) Protease signalling: the cutting edge. EMBO J 31(7):1630\u20131643. doi: 10.1038\/emboj.2012.42","journal-title":"EMBO J"},{"key":"1229_CR12","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nm0898-909","volume":"4","author":"S Even-Ram","year":"1998","unstructured":"Even-Ram S, Uziely B, Cohen P et al (1998) Thrombin receptor overexpression in malignant and physiological invasion processes. Nat Med 4:909\u2013914","journal-title":"Nat Med"},{"key":"1229_CR13","doi-asserted-by":"crossref","first-page":"931","DOI":"10.4049\/jimmunol.171.2.931","volume":"171","author":"CC Taggart","year":"2003","unstructured":"Taggart CC, Greene CM, Smith SG, Levine RL, McCray PB Jr, O\u2019Neill S et al (2003) Inactivation of human beta-defensins 2 and 3 by elastolytic cathepsins. J Immunol 171:931\u2013937","journal-title":"J Immunol"},{"issue":"2","key":"1229_CR14","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1128\/IAI.71.2.838-844.2003","volume":"71","author":"D Moncada","year":"2003","unstructured":"Moncada D, Keller K, Chadee K (2003) Entamoeba histolytica cysteine proteinases disrupt the polymeric structure of colonic mucin and alter its protective function. Infect Immun 71(2):838\u2013844","journal-title":"Infect Immun"},{"key":"1229_CR15","doi-asserted-by":"crossref","first-page":"19706","DOI":"10.1074\/jbc.M101573200","volume":"276","author":"G Denecker","year":"2001","unstructured":"Denecker G, Declercq W, Geuijen CA, Boland A, Benabdillah R, Gurp MV et al (2001) Yersinia enterocolitica YopP-induced apoptosis of macrophages involves the apoptotic signaling cascade upstream of bid. J Biol Chem 276:19706\u201319714","journal-title":"J Biol Chem"},{"key":"1229_CR16","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.4049\/jimmunol.164.7.3476","volume":"164","author":"F Nomura","year":"2000","unstructured":"Nomura F, Akashi S, Sakao Y, Sato S, Kawai T, Matsumoto M et al (2000) Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J Immunol 164:3476\u20133479. doi: 10.4049\/jimmunol.164.7.3476","journal-title":"J Immunol"},{"key":"1229_CR17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1023\/A:1013512912160","volume":"7","author":"S Chattopadhyay","year":"2002","unstructured":"Chattopadhyay S, Das T, Sa G, Ray PK (2002) Protein A-activated macrophages induce apoptosis in Ehrlich\u2019s ascites carcinoma through a nitric oxide-dependent pathway. Apoptosis 7:49\u201357","journal-title":"Apoptosis"},{"issue":"1","key":"1229_CR18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/carcin\/24.1.75","volume":"24","author":"A Bhattacharyya","year":"2003","unstructured":"Bhattacharyya A, Choudhuri T, Pal S, Chattopadhyay S, Datta GK, Sa G et al (2003) Apoptogenic effects of black tea on Ehrlich\u2019s ascites carcinoma cell. Carcinogenesis 24(1):75\u201380. doi: 10.1093\/carcin\/24.1.75","journal-title":"Carcinogenesis"},{"key":"1229_CR19","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1006\/bbrc.2001.5823","volume":"288","author":"S Pal","year":"2001","unstructured":"Pal S, Choudhuri T, Chattopadhyay S, Bhattacharya A, Datta GK, Das T et al (2001) Mechanisms of curcumin-induced apoptosis of Ehrlich\u2019s Ascites Carcinoma cells. Biochem Biophys Res Commun 288:658\u2013665. doi: 10.1006\/bbrc.2001.5823","journal-title":"Biochem Biophys Res Commun"},{"key":"1229_CR20","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s00262-002-0288-0","volume":"51","author":"T Das","year":"2002","unstructured":"Das T, Sa G, Chattopadhyay S, Ray PK (2002) Protein A-induced apoptosis of cancer cells is affected by soluble immune mediators. Cancer Immunol Immunother 51:376\u2013380. doi: 10.1007\/s00262-002-0288-0","journal-title":"Cancer Immunol Immunother"},{"key":"1229_CR21","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/329456a0","volume":"329","author":"JV Gannon","year":"1987","unstructured":"Gannon JV, Lane DP (1987) p63 and DNA polymerase a compete for the binding to SV40 T antigen. Nature 329:456\u2013458","journal-title":"Nature"},{"issue":"19","key":"1229_CR22","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1093\/hmg\/ddn192","volume":"17","author":"M Rosner","year":"2008","unstructured":"Rosner M, Hengstschlager M (2008) Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1. Hum Mol Genet 17(19):2934\u20132948","journal-title":"Hum Mol Genet"},{"issue":"4","key":"1229_CR23","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1128\/JCM.41.4.1548-1557.2003","volume":"41","author":"T Kageyama","year":"2003","unstructured":"Kageyama T, Kojima S, Shinohara M, Uchida K, Fukushi S, Hoshino FB, Takeda N, Katayama K (2003) Broadly reactive and highly sensitive assay for Norwalk-like viruses based on real-time quantitative reverse transcription-PCR. J Clin Microbiol 41(4):1548\u20131557","journal-title":"J Clin Microbiol"},{"key":"1229_CR24","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/carcin\/bgh067","volume":"25","author":"H Kumagai","year":"2004","unstructured":"Kumagai H, Mukaisho K, Sugihara H, Miwa K, Yamamoto G, Hattori T (2004) Thioproline inhibits development of esophageal adenocarcinoma induced by gastroduodenal reflux in rats. Carcinogenesis 25:723\u2013727. doi: 10.1093\/carcin\/bgh067","journal-title":"Carcinogenesis"},{"key":"1229_CR25","first-page":"5","volume":"10","author":"D Ribble","year":"2005","unstructured":"Ribble D, Goldstein NB, Norris DA, Shellman YG (2005) A simple technique for quantifying apoptosis in 96-well plates. BMC Biotechnol 10:5\u201312. doi: 10.1186\/1472-6750-5-12","journal-title":"BMC Biotechnol"},{"issue":"8","key":"1229_CR26","doi-asserted-by":"crossref","first-page":"817","DOI":"10.5551\/jat.2881","volume":"17","author":"T Ray","year":"2010","unstructured":"Ray T, Maity PC, Banerjee S, Deb S, Dasgupta AK, Sarkar S et al (2010) Vitamin C prevents cigarette smoke induced atherosclerosis in guinea pig model. J Atheroscler Thromb 17(8):817\u2013827. doi: 10.5551\/jat.2881","journal-title":"J Atheroscler Thromb"},{"key":"1229_CR27","doi-asserted-by":"crossref","first-page":"6169","DOI":"10.1038\/ncomms7169","volume":"6","author":"B Majumder","year":"2015","unstructured":"Majumder B, Baraneedharan U, Thiyagarajan S, Radhakrishnan P, Narashisimhan H, Dhandapani M et al (2015) Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity. Nat Commun 6:6169. doi: 10.1038\/ncomms7169","journal-title":"Nat Commun"},{"issue":"10","key":"1229_CR28","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1001\/jamasurg.2013.3393","volume":"148","author":"CB Matsen","year":"2013","unstructured":"Matsen CB, Neumayer LA (2013) Breast cancer: a review for the general surgeon. JAMA Surg 148(10):971\u2013979. doi: 10.1001\/jamasurg.2013.3393","journal-title":"JAMA Surg"},{"key":"1229_CR29","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1200\/JCO.1996.14.8.2197","volume":"14","author":"PA Greenberg","year":"1996","unstructured":"Greenberg PA, Hortobagyi GN, Smith TL, Ziegler LD, Frye DK, Buzdar AU (1996) Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer. J Clin Oncol 14:2197\u20132205","journal-title":"J Clin Oncol"},{"key":"1229_CR30","doi-asserted-by":"crossref","unstructured":"Orlando L, Colleoni M, Fedele P, Cusmai A, Rizzo P, D\u2019Amico M et al (2007) Management of advanced breast cancer. Ann Oncol 18(Suppl 6):vi74\u2013vi76. doi: 10.1093\/annonc\/mdm230","DOI":"10.1093\/annonc\/mdm230"},{"key":"1229_CR31","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jss.2007.03.085","volume":"143","author":"CU Ihemelandu","year":"2007","unstructured":"Ihemelandu CU, Leffall LD Jr, Dewitty RL, Naab TJ, Mezghebe HM, Makambi KH et al (2007) Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival. J Surg Res 143:109\u2013118. doi: 10.1016\/j.jss.2007.03.085","journal-title":"J Surg Res"},{"key":"1229_CR32","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.med.58.062105.204854","volume":"58","author":"P Dalerba","year":"2007","unstructured":"Dalerba P, Cho RW, Clarke MF (2007) Cancer stem cells: models and concepts. Annu Rev Med 58:267\u2013284. doi: 10.1146\/annurev.med.58.062105.204854","journal-title":"Annu Rev Med"},{"key":"1229_CR33","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.ygyno.2006.05.048","volume":"103","author":"S Granovsky-Grisaru","year":"2006","unstructured":"Granovsky-Grisaru S, Zaidoun S, Grisaru D, Yekel Y, Prus D, Beller U et al (2006) The pattern of protease activated receptor 1 (PAR1) expression in endometrial carcinoma. Gynecol Oncol 103:802\u2013806. doi: 10.1016\/j.ygyno.2006.05.048","journal-title":"Gynecol Oncol"},{"key":"1229_CR34","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/ijc.20607","volume":"113","author":"S Grisaru-Granovsky","year":"2005","unstructured":"Grisaru-Granovsky S, Salah Z, Maoz M, Pruss D, Beller U, Bar-Shavit R (2005) Differential expression of protease activated receptor 1 (Par1) and pY397FAK in benign and malignant human ovarian tissue samples. Int J Cancer 113:372\u2013378. doi: 10.1002\/ijc.20607","journal-title":"Int J Cancer"},{"key":"1229_CR35","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1158\/1535-7163.MCT-08-0177","volume":"7","author":"A Agarwal","year":"2008","unstructured":"Agarwal A, Covic L, Sevigny LM, Kaneider NC, Lazarides K, Azabdaftari G et al (2008) Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer. Mol Cancer Ther 7:2746\u20132757. doi: 10.1158\/1535-7163.MCT-08-0177","journal-title":"Mol Cancer Ther"},{"key":"1229_CR36","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cell.2004.12.018","volume":"120","author":"A Boire","year":"2005","unstructured":"Boire A, Covic L, Agarwal A, Jacques S, Sherifi S, Kuliopulos A (2005) PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 120:303\u2013313. doi: 10.1016\/j.cell.2004.12.018","journal-title":"Cell"},{"key":"1229_CR37","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1021\/bi9824792","volume":"38","author":"A Kuliopulos","year":"1999","unstructured":"Kuliopulos A, Covic L, Seeley SK, Sheridan PJ, Helin J, Costello CE (1999) Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy. Biochemistry 38:4572\u20134585. doi: 10.1021\/bi9824792","journal-title":"Biochemistry"},{"key":"1229_CR38","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1152\/physrev.00028.2003","volume":"84","author":"VS Ossovskaya","year":"2004","unstructured":"Ossovskaya VS, Bunnett NW (2004) Protease-activated receptors: contribution to physiology and disease. Physiol Rev 84:579\u2013621. doi: 10.1152\/physrev.00028.2003","journal-title":"Physiol Rev"},{"key":"1229_CR39","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1021\/ml2002696","volume":"3","author":"C Dockendorff","year":"2012","unstructured":"Dockendorff C, Aisiku O, VerPlank L, Dilks JR, Smith DA, Gunnink SF et al (2012) Discovery of 1,3-diaminobenzenes as selective inhibitors of platelet activation at the PAR1 receptor. ACS Med Chem Lett 3:232\u2013237. doi: 10.1021\/ml2002696","journal-title":"ACS Med Chem Lett"},{"key":"1229_CR40","doi-asserted-by":"crossref","first-page":"11023","DOI":"10.1073\/pnas.96.20.11023","volume":"96","author":"SR Coughlin","year":"1999","unstructured":"Coughlin SR (1999) How the protease thrombin talks to cells. Proc Natl Acad Sci USA 96:11023\u201311027. doi: 10.1073\/pnas.96.20.11023","journal-title":"Proc Natl Acad Sci USA"},{"key":"1229_CR41","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1042\/bj20030346","volume":"375","author":"CJ Chalmers","year":"2003","unstructured":"Chalmers CJ, Balmanno K, Hadfield K, Ley R, Cook SJ (2003) Thrombin inhibits Bim (Bcl-2-interacting mediator of cell death) expression and prevents serum-withdrawal-induced apoptosis via protease-activated receptor 1. Biochem J 375:99\u2013109. doi: 10.1042\/bj20030346","journal-title":"Biochem J"},{"key":"1229_CR42","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1182\/blood.V96.8.2784","volume":"96","author":"EA Lidington","year":"2000","unstructured":"Lidington EA, Haskard DO, Mason JC (2000) Induction of decay accelerating factor by thrombin through a protease-activated receptor 1 and protein kinase C-dependent pathway protects vascular endothelial cells from complement-mediated injury. Blood 96:2784\u20132792","journal-title":"Blood"},{"key":"1229_CR43","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/hep.510270524","volume":"27","author":"H Mitsui","year":"1998","unstructured":"Mitsui H, Maruyama T, Kimura S, Takuwa Y (1998) Thrombin activates two stress-activated protein kinases, c-Jun N-terminal kinase and p38, in HepG2 cells. Hepatology 27:1362\u20131367. doi: 10.1002\/hep.510270524","journal-title":"Hepatology"},{"key":"1229_CR44","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1182\/blood.V98.3.667","volume":"98","author":"V Marin","year":"2001","unstructured":"Marin V, Farnarier C, Gres S, Kaplanski S, Su MS, Dinarello CA, Kaplanski G (2001) The p38 mitogen activated protein kinase pathway plays a critical role in thrombin-induced endothelial chemokine production and leukocyte recruitment. Blood 98:667\u2013673. doi: 10.1182\/blood-2002-11-3338","journal-title":"Blood"},{"key":"1229_CR45","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1161\/01.CIR.0000142867.26182.32","volume":"110","author":"XF Ming","year":"2004","unstructured":"Ming XF, Barandier C, Viswambharan H, Kwak BR, Mach F, Mazzolai L, Hayoz D, Ruffieux J, Rusconi S, Montani JP, Yang Z (2004) Thrombin stimulates human endothelial arginase enzymatic activity via RhoA\/ROCK pathway: implications for atherosclerotic endothelial dysfunction. Circulation 110:3708\u20133714. doi: 10.1161\/01.CIR.0000142867.26182.32","journal-title":"Circulation"},{"key":"1229_CR46","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1161\/01.RES.0000033520.95242.A2","volume":"91","author":"A Rahman","year":"2002","unstructured":"Rahman A, True AL, Anwar KN, Ye RD, Voyno-Yasenetskaya TA, Malik AB (2002) Galpha(q) and Gbetagamma regulate PAR-1 signaling of thrombin-induced NF-kappaB activation and ICAM-1 transcription in endothelial cells. Circ Res 91:398\u2013405. doi: 10.1161\/01.RES.0000033520.95242.A2","journal-title":"Circ Res"},{"issue":"1","key":"1229_CR47","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/10286020.2010.540757","volume":"13","author":"WJ Duan","year":"2011","unstructured":"Duan WJ, Li QS, Xia MY, Tashiro S, Onodera S, Ikejima T (2011) Silibinin activated ROS-p38-NF-\u03baB positive feedback and induced autophagic death in human fibrosarcoma HT1080 cells. J Asian Nat Prod Res 13(1):27\u201335. doi: 10.1080\/10286020.2010.540757","journal-title":"J Asian Nat Prod Res"},{"key":"1229_CR48","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0014-5793(98)01036-9","volume":"435","author":"A Lourbakos","year":"1998","unstructured":"Lourbakos A, Chinni C, Thompson P, Potempa J, Travis J, Mackie EJ et al (1998) Cleavage and activation of proteinase-activated receptor-2 on human neutrophils by gingipain-R from Porphyromonas gingivalis. FEBS Lett 435:45\u201348. doi: 10.1016\/S0014-5793(98)01036-9","journal-title":"FEBS Lett"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-016-1229-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10495-016-1229-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-016-1229-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T21:38:48Z","timestamp":1600205928000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10495-016-1229-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,20]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["1229"],"URL":"https:\/\/doi.org\/10.1007\/s10495-016-1229-2","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,20]]}}}